A 24-Week Randomized, Double-Blind, Active-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Rosiglitazone When Administered to Pediatric Patients with Type 2 Diabetes Mellitus

  • Thrailkill, Kathryn (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date11/1/008/31/02